- Analytica Investor
- Posts
- 📊 Biotech Rockets, Toys Pop & AI Anime Crashes Hard
📊 Biotech Rockets, Toys Pop & AI Anime Crashes Hard
A 70% biotech surge, a $100M toy play, and an AI streamer in freefall, here’s what moved.
Matthias Schneider
June 23, 2025
Good morning, investors
This week’s market saw biotech optimism, strategic toy deals, and AI exuberance take a hit. Citius Oncology $CTOR ( ▲ 1.34% ) led the charge, rocketing on plans to commercially launch its cancer therapy LYMPHIR™ in 2025. Meanwhile, SRM Entertainment $SRM ( ▲ 10.81% ) went full throttle, boosted by a $100M equity injection tied to its TRON Treasury Strategy.
But not all stories had happy endings: AI-driven streaming firm GIBO Holdings $GIBO ( ▼ 29.6% ) plunged with no press in sight, and Galectin $GALT ( ▲ 0.46% ) lost last week’s gains almost as fast as they came.
Momentum remains fickle investor buzz can fuel a breakout or burn it down. Keep your eyes open.
Matthias Schneider
Editor at Analytica Investor